| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 12/13/2007 | US20070286862 Cancer Associated Antigens |
| 12/13/2007 | US20070286861 Therapeutic antibody specific for oncostatin M for use in treatment and diagnosis of rheumatoid arthritis, juvenile onset arthritis or osteoarthritis |
| 12/13/2007 | US20070286859 Fc Variants Having Decreased Affinity for FcyRl |
| 12/13/2007 | US20070286858 Methods and Compositions for Antagonism of RAGE |
| 12/13/2007 | US20070286857 Anti-Cd52 Antibody Treatment for Diabetes |
| 12/13/2007 | US20070286856 Enzyme is a drug target; cancer, inflammatory diseases such as psoriasis |
| 12/13/2007 | CA2771971A1 Gene involved in immortalization of human cancer cell and use thereof |
| 12/13/2007 | CA2657946A1 Modified protein toxins targeting cytokine -receptor bearing cells and use thereof for treating disease |
| 12/13/2007 | CA2654978A1 Gene involved in immortalization of human cancer cell and use thereof |
| 12/13/2007 | CA2654712A1 Human binding molecules having killing activity against staphylococci and uses thereof |
| 12/13/2007 | CA2654623A1 An anti-nr10/il-31ra antibody for use in preventing or treating an inflammatory disease |
| 12/13/2007 | CA2654572A1 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| 12/13/2007 | CA2654502A1 Human binding molecules having killing activity against enterococci and uses thereof |
| 12/13/2007 | CA2654330A1 Monoclonal anti-annexin a3 antibodies for the detection of prostate carcinoma |
| 12/13/2007 | CA2654025A1 Hepatocyte growth factor (hgf) binding proteins |
| 12/13/2007 | CA2654019A1 Hepatocyte growth factor (hgf) binding proteins |
| 12/13/2007 | CA2653966A1 Perforin-2 proteins |
| 12/13/2007 | CA2653444A1 Blood-brain barrier targeting antibodies |
| 12/13/2007 | CA2652976A1 High affinity antibodies to human il-6 receptor |
| 12/13/2007 | CA2589393A1 Ligand for g-protein coupled receptor gpr72 and uses thereof |
| 12/12/2007 | EP1865325A1 Method of screening for cancer and adenoma |
| 12/12/2007 | EP1865061A2 IL-17 homologous polypeptides and therapeutic uses thereof |
| 12/12/2007 | EP1865060A1 Transcriptional Intermediary Factor-2 |
| 12/12/2007 | EP1865058A1 Anti-cd-20 monoclonal antibody |
| 12/12/2007 | EP1865053A2 Method for modifying plant morphology, biochemistry and physiology comprising expression of plant cytokinin oxidase |
| 12/12/2007 | EP1865001A1 Specific protease inhibitors and their use in cancer therapy |
| 12/12/2007 | EP1865000A1 Monoclonal antibody specific to denatured human leukocyte antigen class i |
| 12/12/2007 | EP1864999A1 Affinity purification of polypeptide on protein a matrix |
| 12/12/2007 | EP1864998A2 Binding molecules |
| 12/12/2007 | EP1864996A1 Peptide associated with rheumatic fever (PARF) and its use as a diagnostic marker. |
| 12/12/2007 | EP1864678A1 Pigment epithelium-derived factor: characterization, genomic organization and sequence of the PEDF gene |
| 12/12/2007 | EP1864134A2 Methods to treat or prevent hormone-resistant prostate cancer using sirna specific for protocadherin-pc, or other inhibitors of protocadherin-pc expression or activity |
| 12/12/2007 | EP1864131A2 Natural ligand of g protein coupled receptor rcc356 and uses thereof |
| 12/12/2007 | EP1864129A1 Doxorubicin immunoassay |
| 12/12/2007 | EP1863849A2 Rodent pest control |
| 12/12/2007 | EP1863846A2 Human synthetic single-chain antibodies directed against the common epitope of mutant p53 and their uses |
| 12/12/2007 | EP1863845A2 Antibodies against candida antigens |
| 12/12/2007 | EP1863844A1 Heterodimeric protein binding compositions |
| 12/12/2007 | EP1863835A2 Vaccine and antibodies against parasitic nematodes |
| 12/12/2007 | EP1863532A1 Anti-ctla4 antibody and indolinone combination therapy for treatment of cancer |
| 12/12/2007 | EP1863531A1 Improvements in or relating to treatment and prevention of viral infections |
| 12/12/2007 | EP1863530A1 Methods for damaging cells using effector functions of anti-gfra1 antibodies |
| 12/12/2007 | EP1863525A2 Polypeptides |
| 12/12/2007 | EP1863340A2 Gene disruptions, compositions and methods relating thereto |
| 12/12/2007 | EP1773883A4 Antibodies against cancer produced using masked cancer cells as immunogen |
| 12/12/2007 | EP1644740A4 Assessment of skeletal growth using measurements of nt-cnp peptides |
| 12/12/2007 | EP1237912B1 Five-helix protein |
| 12/12/2007 | EP1144454B1 Modified peptides as therapeutic agents |
| 12/12/2007 | EP1009833B1 Prenylcysteine carboxyl methyl-transferase, dna enconding same, and a method of screening for inhibitors thereof |
| 12/12/2007 | EP0894130B1 Modulators of tnf receptor associated factor (traf), their preparation and use |
| 12/12/2007 | EP0888377B1 MURINE alpha(1,3)-FUCOSYLTRANSFERASE (Fuc-TVII) |
| 12/12/2007 | EP0723555B1 Chimeric proteins which block complement activation |
| 12/12/2007 | CN101087877A Anti-human soluble fibrin monoclonal antibody and immunological assay method using the antibody |
| 12/12/2007 | CN101087807A Method for treating vasculitis |
| 12/12/2007 | CN101087806A Immunoglobulins comprising predominantly a Ga1GlcNAcMan5GLcNAc2 glycoform |
| 12/12/2007 | CN101087637A Purification of immunoglobulins |
| 12/12/2007 | CN101085812A SARS coronavirus polypeptide antigen and application thereof |
| 12/12/2007 | CN101085811A SARS coronavirus pharmaceutical target and application thereof |
| 12/12/2007 | CN100354308C Novel alginate monoclonal antibody and its preparation method and uses |
| 12/12/2007 | CN100354307C NOGO receptor-mediated blockade of axonal growth |
| 12/12/2007 | CN100354305C Mage-A1 peptides presented by HLA class II molecules |
| 12/12/2007 | CN100354304C Breast cancer related gene DREE, its coded protein and uses |
| 12/12/2007 | CN100354303C GIBC gene and its coded protein and uses |
| 12/12/2007 | CN100354284C Preparation of triazoline artificial semi-antigen, antigen and antibody |
| 12/11/2007 | US7307154 DNA encoding a novel RG1 polypeptide |
| 12/11/2007 | US7307153 Antibodies that bind PRO9912 |
| 12/11/2007 | US7307152 Monoclonal antibody specific for epidermal growth factor for use in diagnosis, prevention and treatment of skin, kidney, muscular and inflammatory disorders |
| 12/11/2007 | US7307151 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/11/2007 | US7307146 Mamalian chemokines and 7 transmembrane receptors; bound to MIP-3 alpha; labeled; fused to luciferase, bacterial beta -galactosidase, trpE, Protein A, beta -lactamase, alpha amylase, alcohol dehydrogenase, a FLAG tag, or yeast alpha mating factor; complexed with an antibody |
| 12/11/2007 | US7307144 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
| 12/11/2007 | US7307064 Methods for treating cardiovascular disease using a soluble CTLA4 molecule |
| 12/11/2007 | US7306925 Phage antibodies to radiation-inducible neoantigens |
| 12/11/2007 | US7306922 Human and rat PGC-3, PPAR-gamma coactivations and splice variants thereof |
| 12/11/2007 | US7306920 Gene associated with regulation of energy balance, obesity and diabetes and uses therefor |
| 12/11/2007 | US7306907 Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors |
| 12/11/2007 | US7306808 Orientia tsutsugamushi truncated recombinant outer membrane protein (r47) and (r57) vaccines diagnostics and therapeutics for scrub typhus |
| 12/11/2007 | US7306801 Methods of therapy for cancers characterized by overexpression of the HER2 receptor protein |
| 12/11/2007 | US7306800 Monoclonal antibody that recognizes a human 8F4 polypeptide, wherein 8F4 polypeptide: is an inducible T cell costimulatory molecule; occurs on two-signal-activated CD4+ T lymphocytes from human peripheral blood; dimer of two peptide chains |
| 12/11/2007 | US7306798 For AIDS and as a diagnostic tool or as a preventative and curative medicament; selectively binds the R7V epitope of the gp160 protein of the HIV-1 virus |
| 12/11/2007 | US7306797 Use of a compound antagonist of ESM-1 protein for producing a medicine for treating cancer |
| 12/11/2007 | US7306795 PRO5774 antibodies |
| 12/11/2007 | US7306782 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases |
| 12/11/2007 | CA2259141C Treatment and diagnosis of infections of gram positive cocci |
| 12/06/2007 | WO2007140434A2 Immune-derived moieties reactive against lysophosphatidic acid |
| 12/06/2007 | WO2007140433A2 Methods and reagents for detecting bioactive lipids |
| 12/06/2007 | WO2007140431A2 Novel bioactive lipid derivatives, immune-derived moieties reactive thereto, and methods of making and using the same |
| 12/06/2007 | WO2007140371A2 Antibodies and immunoconjugates and uses therefor |
| 12/06/2007 | WO2007139359A1 Vcam-1 specific monoclonal antibody |
| 12/06/2007 | WO2007139208A1 Pharmaceutical composition for prevention or treatment of disease associated with platelet adhesion/aggregation reaction, and method for screening for the same |
| 12/06/2007 | WO2007139164A1 Humanized anti-human osteopontin antibody |
| 12/06/2007 | WO2007138691A1 Polycystic kidney disease-related gene and use thereof |
| 12/06/2007 | WO2007138444A2 Genetic markers for high oleic acid content in plants |
| 12/06/2007 | WO2007138163A2 Antibodies and standard for nt-probnp and probnp immunoassays |
| 12/06/2007 | WO2007137984A2 Modified humanised anti-interleukin-18 antibodies |
| 12/06/2007 | WO2007137760A2 Dimeric molecular complexes |
| 12/06/2007 | WO2007118986A3 Concentrate of immunoglobulins and f(ab)'2 and/or fab fragments specific of an arbovirus as medicine |
| 12/06/2007 | WO2007113598A3 Peptide mimetope vaccine of- and antibodies against 6b pneumococcal polysaccharides |
| 12/06/2007 | WO2007095152A3 Transducible delivery of sirna by dsrna binding domain fusions to ptd/cpps |
| 12/06/2007 | WO2007080174A3 Chimeric and humanised anti-human il-13 antibodies |
| 12/06/2007 | WO2007062245A3 Human monoclonal antibody human cd134 (ox40) and methods of making and using same |